Publications by authors named "A Carotti"

Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) accounts for the catabolism of the endogenous inhibitors of nitric oxide (NO) synthases, namely, ADMA (,-dimethyl-l-arginine) and NMMA (-monomethyl-l-arginine). Inhibition of DDAH-1 may prove a therapeutic benefit in diseases associated with elevated nitric oxide (NO) levels by providing a tissue-specific increase of ADMA and NMMA. In this work, we have used molecular dynamics to generate a pool of DDAH-1 conformations in the apo and holo forms.

View Article and Find Full Text PDF

Riluzole, the first clinically approved treatment for amyotrophic lateral sclerosis (ALS), represents a successful example of a drug endowed with a multimodal mechanism of action. In recent years, different series of riluzole-based compounds have been reported, including several agents acting as Multi-Target-Directed Ligands (MTLDs) endowed with neuroprotective effects. Aiming at identical twin structures inspired by riluzole (2a-c), a synthetic procedure was planned, but the reactivity of the system took a different path, leading to the serendipitous isolation of benzo[b][1,4]thiazepines 3a-c and expanded intermediates N-cyano-benzo[b][1,4]thiazepines 4a-c, which were fully characterized.

View Article and Find Full Text PDF

Background: Innovations in computer hardware and software capabilities have paved the way for advances in molecular modelling techniques and methods, leading to an unprecedented expansion of their potential applications. In contrast to the docking technique, which usually identifies the most stable selector-selectand (SO-SA) complex for each enantiomer, the molecular dynamics (MD) technique enables the consideration of a distribution of the SO-SA complexes based on their energy profile. This approach provides a more truthful representation of the processes occurring within the column.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines long-term arrhythmia incidence in patients who underwent the extracardiac conduit-Fontan procedure for univentricular heart palliation over a follow-up period from 1987 to 2017.
  • Out of 353 patients tracked for at least 5 years, 28% experienced arrhythmias, with a notable increase in late tachyarrhythmias after 12 years, particularly affecting those with a systemic right ventricle.
  • The findings highlight that extracardiac conduit procedures are linked to a significant risk of arrhythmias over the long term, emphasizing the need for careful monitoring, especially in patients with systemic right ventricle morphology.
View Article and Find Full Text PDF